Endocrine Abstracts

Introduction: A growing body of evidence supports the possible association between the severity of climacteric symptoms and long-term cardiometabolic risk. We aimed to assess the possible link between the severity of hot flashes and the risk for cardiometabolic manifestations after the menopausal transition.Methods: This cohort study was conducted in the Menopause Clinic, National and Kapodistrian University of Athens, Aretaieio Hospital, Athens, Greece....

Introduction: Differences in the prevalence and prognosis of cardiovascular disease have been linked with gender specific risk factors as well as the differential impact of sex hormones. Moreover, specific genetic polymorphisms may increase further the risk of cardiovascular disease development. Polymorphisms of genes encoding the NADPH/NADPH oxidase system and the endothelial nitric oxide synthase (eNOS) have been associated with atherosclerosis in the general population, but...

Introduction: The prevalence of cardiovascular disease in reproductively active women has received limited attention. Recent data indicated possible adverse effect of non-typical obstetrical risk factors with regards to cardiovascular function. We aimed to evaluate the potential association between anti-mullerian hormone (AMH), a known marker of ovarian reserve, with subclinical atherosclerosis in young premenopausal women.Methods: This was a cross-secti...

IntroductionMenopausal transition has been associated with an increase in cardiovascular risk, which is possibly linked with the hormonal imbalance following ovarian senescence. Both insulin levels and circulating androgens (FAI) have been associated with endothelial dysfunction, through studies evaluating flow mediated dilation (FMD). We aimed to investigate whether the link between these hormones and FMD might be explained by markers of oxidative stres...

Objective: Prolactin has been adversely associated with arterial function in postmenopausal women but its vascular effects in reproductive women are unknown. Furthermore, although both circulating prolactin levels and markers of vascular function follow menstrual cycle (MC) phases, their possible inter-correlation has not been explored.Methods: Sixty healthy premenopausal women were evaluated in two distinct phases of their MC (follicular, F and luteal p...

Background: Recent data is indicating that levels of circulating amyloid β 1-40 (αβ1-40), a proatherogenic aging peptide, may be considered as a novel biomarker in cardiovascular disease (CVD). Postmenopausal women represent a population with substantial unrecognized CVD-risk, which would benefit from identification of novel cardiovascular risk markers.Aim: To explore the role of plasma Aβ1-40 and its patterns of change over time in a...